Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.590
0.00 (0.00%)
May 7, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $8.82 million as of May 7, 2026. Its market cap has decreased by -36.27% in one year.
Market Cap
8.82M
Enterprise Value
4.27M
1-Year Change
-36.27%
Ranking
Category
Stock Price
$4.59
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $8.82M, a decrease of -98.72%. That is a compound annual growth rate of -56.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 8.82M | -15.96% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.99M |
| CalciMedica | 9.80M |
| PMGC Holdings | 9.48M |
| Liminatus Pharma | 9.20M |
| NuCana | 9.20M |
| XTL Biopharmaceuticals | 8.47M |
| Evogene | 8.36M |
| PharmaCyte Biotech | 8.27M |